Keywords: Almirall, Proteros, Inflammatory diseases, Drug discovery

Almirall enters integrated discovery agreement with Proteros

Article | 22 September 2011

Print This

Spain’s largest pharma company Almirall (ALM. MC) and privately-held German firm Proteros biostructures GmbH have entered into a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in